3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Colorectal Neoplasms
20
Pancreatic Neoplasms
11
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Rectal Neoplasms
5
Colonic Neoplasms
5
Thyroid Neoplasms
4
Multiple Myeloma
4
Cholangiocarcinoma
4
Biliary Tract Neoplasms
4
Neoplasm Metastasis
3
Melanoma
3
Hematologic Neoplasms
3
Glioma
3
Breast Neoplasms
3
Bile Duct Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Stromal Tumors
2
Carcinoma, Hepatocellular
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Stomach Neoplasms
1
Interventions
Radiotherapy
2
Polymerase Chain Reaction
2
Nicotine
2
Gene Expression Profiling
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Counseling
2
Bupropion
2
trametinib
1
pembrolizumab
1
motexafin gadolinium
1
fluoromisonidazole
1
durvalumab
1
dabrafenib
1
cobimetinib
1
Zinc Oxide
1
Vemurafenib
1
Varenicline
1
Tobacco Use Cessation Devices
1
Taxes
1
Surgical Procedures, Operative
1
Sucralfate
1
Salts
1
Rubidium-82
1
Ritonavir
1
Radiotherapy, Intensity-Modulated
1
Quality of Life
1
Psychiatric Rehabilitation
1
Pemetrexed
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
trametinib
×
Gastrointestinal
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled